|
|
.
See Category: Diseases of the genitourinary system
See Header: Fibrosclerosis of breast
ICD-10 (CM) Code and Descriptor
|
N60.31 |
Fibrosclerosis of right breast
|
N6031 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 36.38%
|
29.95%
|
16.88%
|
8.47%
|
3.93%
|
2.05%
|
0.73%
|
0.61%
|
0.35%
|
0.24%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N60.31*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,397
|
2,799
|
|
77065
|
DX MAMMO INCL CAD UNI |
1,513
|
1,515
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
1,352
|
1,497
|
|
19083
|
BX BREAST 1ST LESION US IMAG |
1,349
|
1,349
|
|
19081
|
BX BREAST 1ST LESION STRTCTC |
734
|
734
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
490
|
553
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
380
|
380
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
337
|
625
|
|
J3010
|
FENTANYL CITRATE INJECTION |
287
|
428
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
269
|
7,285
|
|
J2405
|
ONDANSETRON HCL INJECTION |
259
|
1,105
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
243
|
317
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
226
|
1,732
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
201
|
774
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
190
|
1,251
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
186
|
192
|
|
77066
|
DX MAMMO INCL CAD BI |
168
|
168
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
167
|
339
|
|
J2001
|
LIDOCAINE INJECTION |
160
|
1,885
|
|
76642
|
ULTRASOUND BREAST LIMITED |
144
|
145
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N60.31 related to the following DRG Codes:
600-601
|
